C81.22

Clinical Causes: Genetic predisposition may play a role, although specific genes are still under research. Exposure to certain viruses, such as the Epstein-Barr virus (EBV), has been linked with an increased risk. Environmental factors, including exposure to certain pesticides or chemicals, are being studied as potential contributors. A weakened immune system, either from autoimmune diseases or immunosuppressive treatments, can increase susceptibility. History of prior radiation therapy in the chest area has been associated with an increased risk.

Key Symptoms: Swelling or painless lumps in the neck, chest, or underarms. Persistent cough or difficulty breathing, especially if the chest lymph nodes are enlarged. Unexplained weight loss seen over weeks or months. Fever that comes and goes without an obvious cause. Night sweats causing soaking of clothes or bedding. Fatigue or general feeling of being unwell. Itching that may be widespread or localized.

Diagnosis Path: Diagnosing mixed cellularity Hodgkin lymphoma involves a combination of clinical examination, imaging tests, and biopsy procedures. Initially, a doctor may recommend imaging modalities such as chest X-rays, computed tomography (CT) scans, or positron emission tomography (PET) scans to identify enlarged lymph nodes. The definitive diagnosis is made by obtaining a tissue sample through a biopsy, where pathologists examine the cells under a microscope and perform immunohistochemical testing to identify Reed-Sternberg cells. Additional blood tests may be conducted to assess overall health and to support staging of the disease.

Treatment Protocols: Treatment options typically involve chemotherapy, radiation therapy, or a combination of both. The specific regimen depends on the extent of the disease, patient's overall health, and response to initial therapies. Chemotherapy drugs used may include ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine), which is standard for Hodgkin lymphoma. In some cases, targeted therapies or immunotherapy agents are considered. For early-stage disease, involved-field radiotherapy might be recommended post-chemotherapy. Regular follow-up examinations are essential to monitor for recurrence, manage side effects, and ensure overall well-being. Supportive care, including managing symptoms and maintaining immune health, also plays an important role during treatment.